Second Alpha Raises Oversubscribed $170 Million Fund V
New York-based specialist private equity firm focuses on secondary direct investments in growth-stage tech companies...
Globe Newswire28-02-2023, 17:09
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer 30-05-2025, 17:00